In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
Closed Pre-Solicitation Posted
- Solicitation number
- NIH_NIDA75N95025XXXX
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621512 Diagnostic Imaging Centers
- Place of performance
- Bethesda, Maryland 20892, United States
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Health and Human Services' National Institute on Drug Abuse is seeking proposals for advanced non-invasive optical imaging techniques to address challenges in biological system imaging. The initiative aims to develop next-generation imaging approaches that can overcome significant light scattering limitations in current technologies, ultimately enabling deeper tissue imaging with improved spatial and temporal resolution. Eligible applicants will be expected to propose innovative solutions that enhance optical imaging penetration depth and resolution in biological systems. The solicitation is structured as a UG3/UH3 mechanism with clinical trials explicitly not allowed. Key submission dates include a Letter of Intent due date of February 7, 2025, and a full Application Due Date of March 7, 2025 by 5:00 PM local time, with proposals to be submitted through the NIH grants system.
This pre-solicitation notice does not indicate any specific set-aside designations and does not mention incumbent contractors or precise award values. The opportunity is categorized under Diagnostic Imaging Centers (NAICS 621512) and Medical Imaging Equipment and Supplies (PSC 6525), suggesting potential awards will target research institutions, medical technology developers, and advanced imaging laboratories. While specific budget ranges are not disclosed, the comprehensive nature of the research initiative implies substantial funding potential for successful proposals. Interested parties are encouraged to submit Letters of Intent, which while not mandatory, are recommended to facilitate review processes and prevent unnecessary proposal development. Potential applicants with technical questions are directed to contact nioi@od.nih.gov for additional guidance and clarification.
Notice text
In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed RFA-RM-24-012
The purpose of the Advancing Non-Invasive Optical Imaging Approaches for Biological Systems initiative is to overcome the problem of light scattering in biological systems. Current optical imaging techniques that are non-invasive and allow rapid assessment of tissue function and structure suffer from strong light scattering within biological tissues, limiting the penetration depth and resolution. This funding opportunity encourages development of next-generation non-invasive or minimally-invasive optical imaging techniques to overcome these issues and to allow deeper imaging of biological systems with high spatial and temporal resolution.
Posted Date: December 2, 2024
Open Date (Earliest Submission Date): February 7, 2025
Letter of Intent Due Date(s): February 7, 2025
Application Due Date: March 7, 2025 by 5:00 PM local time of applicant organization.
Please read the full announcement for details https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-24-012.html
Letters of intent while not required are highly encouraged. Letters of intent are helpful for setting up reviews of proposal and may prevent un-necessary work by applicants.
Please send any questions to nioi@od.nih.gov
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity